Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptotagmin-2 (SYT2) is a synaptic vesicle membrane protein and a major calcium sensor that regulates neurotransmitter release at synapses. It contains two C2 domains (C2A and C2B) that bind calcium ions and phospholipids, triggering rapid fusion of synaptic vesicles with the presynaptic plasma membrane. SYT2 is essential for proper synaptic transmission, especially at neuromuscular junctions, and its loss leads to severe motor dysfunction and impaired synaptic transmission.
Calcium-dependent binding to phospholipids and SNARE proteins, triggering synaptic vesicle fusion and neurotransmitter release.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptotagmin-2 (SYT2).